Have to chuckle every time someone brings up listing in the US
On a serious note, Aussie biotechs listed on the ASX (dual listed or not) have been very innovative and performing quite well in 2024 both fundamentally and SP-wise. Some are expecting M&A activity in the next 1-2 years including RAC (may be in 2 years?) that will bring even more focus to ASX biotechs.
RAC - Charts & Price Action, page-21089
-
- There are more pages in this discussion • 1,112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.67 |
Change
0.040(2.46%) |
Mkt cap ! $287.1M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.64 | $197.3K | 117.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7972 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 940 | 1 |
View Market Depth
| Last trade - 15.00pm 12/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |